Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study

Conclusions
Among patients undergoing coronary stenting, those with PAD have more ischemic and bleeding events versus those without PAD. Extended duration dual antiplatelet therapy is associated with consistent ischemic benefit and bleeding harm among patients with and without PAD.

Source: Journal of the American College of Cardiology: Cardiovascular Interventions - May 1, 2017 Category: Cardiology Authors: Secemsky, E. A., Yeh, R. W., Kereiakes, D. J., Cutlip, D. E., Steg, P. G., Massaro, J. M., Apruzzese, P. K., Mauri, L., Dual Antiplatelet Therapy Study Investigators Tags: Peripheral Source Type: research